Abstract
The enzymatic assay of creatine kinase (CK) activity in serum was established in 1959 by Okinaka’s group including Dr. Ebashi. As a biomarker of muscle cell injury,1 the activity assay has been a main procedure to make the precise diagnosis among most markers. It is my honor and privilege to appreciate Dr. Setsuro Ebashi and his wife, Dr. Fumiko Ebashi, for their discovery of troponin (Tn) in skeletal muscle and cardiac muscle and their contribution to the clinical research of a variety of skeletal and cardiac muscle diseases or syndromes, as well as the biological significance.2
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
20.13. References
S. Okinaka, H. Sugita, H. Momoi, and S. Ebashi, et al., Serum creatine phosphokinase and aldolase activity in neuromuscular disorders. Trans. Am. Neurol. Assoc. 84, 62–64 (1959).
S. Ebashi, Y. Nonomura, and T. Toyo-oka, et al., Regulation of muscle contraction by the calciumtroponin-tropomyosin system, Symp. Soc. Exp. Biol. (Cambridge Univ. Press) 30, 349–360 (1976).
Hypertension and coronary heart disease: classification and criteria for epidemiological studies, WHO Tech. Support. Ser. 168, 3–28 (1959).
H. A. Katus, A. Remppis, and F. J. Neumann, et al., Diagnostic efficiency of troponin T measurements in acute myocardial infarction, Circulation 83, 902–912 (1991).
A. S. Jaffe, J. Ravkilde, and R. Roberts, et al., It’s time for a change to a troponin standard, Circulation 102, 1216 (2000).
O. Bazzino, J. J. Fuselli, and F. Botto, et al., PACS group of investigators. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes, Eur. Heart J. 25, 859–866 (2004).
H. A. Katus, A. Remppis, Sheffold, et al., Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction, J. Am. Coll. Cardiol. 67, 1360–1367 (1991).
H. A. Katus, A. Remppis, and F. J. Neumann, et al., Diagnostic efficiency of troponin T measurements in acute myocardial infarction, Circulation 83, 902–912 (1991).
J. E. Adams 3rd, G. A. Sicard, and B. T. Allen, et al., Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I, N. Engl. J. Med. 330, 670–674 (1994).
M. D. McLaurin, F. S. Apple, and E. M. Voss, et al., Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle, Clin. Chem. 43, 976–982 (1997).
V. Ricchiuti, E. M. Voss, and A. Ney, et al., Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim, Clin. Chem. 44, 1919–1924 (1998).
T. Katsuki, T. Toyo-oka, and T. Takayasu, et al., Differences in regulatory mechanisms of atrial and ventricular muscle contraction in bovine heart, Jpn Circ. J. 52, 376–384 (1988).
T. Toyo-oka, J. Ross Jr, Ca2+ sensitivity change and troponin loss in cardiac natural actomyosin after coronary occlusion, Am. J. Physiol. 240, H704–H708 (1981).
J. L. McDonough, D. K. Arrell, and J. E. Van Eyk, et al., Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury, Circ. Res. 84, 9–20 (1999).
C. W. Hamm, C. Heeschen, and B. Goldmann, et al., Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) study investigators, N. Engl. J. Med. 340, 1623–1629 (1999).
E. M. Voss, S. W. Sharkey, and A. E. Gernert, et al., Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium: infarct sizing using serum profiles, Arch. Pathol. Lab. Med. 119, 799–806 (1995).
V. Ricchiuti, S. W. Sharkey, and M. M. Murakami, et al., Cardiac troponin I and T alterations in dog hearts with myocardial infarction: correlation with infarct size, Am. J. Clin. Pathol. 110, 241–247 (1998).
T. Toyo-oka, T. Kawada, and J. Nakata, et al., Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction, Proc. Natl. Acad. Sci. USA 101, 7381–7385 (2004).
T. Toyo-oka, T. Shimizu, and T. Masaki, Inhibition of proteolytic activity of calcium activated neutral protease by leupeptin and antipain, Biochem. Biophys. Res. Commun. 82, 484–491 (1978).
T. Toyo-oka, and T. Masaki, Calcium-activated neutral protease from bovine ventricular muscle: isolation and some of its properties, J. Mol. Cell. Cardiol. 11, 769–786 (1979).
H. Yoshida, M. Takahashi, and M. Koshimizu, et al., Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction, Cardiovasc. Res. 59, 419–427 (2003).
M. Takahashi, K. Tanonaka, and H. Yoshida, et al., Effects of ACE inhibitor and AT(1) blocker on dystrophin-related proteins and calpain in failing heart, Cardiovasc. Res. 65, 356–365 (2005).
K. Wildenthal, J. S. Crie, J. M. Ord, and J. R. Wakeland, The role of lysosomes and microtubules in cardiac protein degradation, Adv. Myocardiol. 5, 137–144 (1985).
M. H. Glickman, A. Ciechanover, The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction, Physiol. Rev. 82, 373–428 (2002).
A. G. Katrukha, A. V. Bereznikova, and V. L. Filatov, et al., Degradation of cardiac troponin I: implication for reliable immunodetection, Clin. Chem. 44, 2433–2440 (1998).
Q. Shi, M. Ling, and X. Zhang, et al., Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays, Clin. Chem. 45, 1018–1025 (1999).
E. Missov, C. Calzolari, and B. Pau, Circulating cardiac troponin I in severe congestive heart failure, Circulation 96, 2953–2958 (1997).
M. Galvani, F. Ottani, and D. Ferrini, et al., Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina, Circulation 95, 2053–2059 (1997).
C. W. Hamm, C. Heeschen, and B. Goldmann, et al., Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) study investigators, N. Engl. J. Med. 340, 1623–1629 (1999).
P. Stubbs, P. Collinson, and D. Moseley, et al., Prognostic significance of admission troponin T concentrations in patients with myocardial infarction, Circulation 94, 1291–1297 (1996).
J. E. D. Adams, G. S. Bodor, and V. G. Davila-Roman, et al., Cardiac troponin I: a marker with high specificity for cardiac injury, Circulation 88, 101–106 (1993).
F. M. Fink, N. Genser, and C. Fink, et al., Cardiac troponin T and creatine kinase MB mass concentrations in children receiving anthracycline chemotherapy, Med. Pediatr. Oncol. 25, 185–189 (1995).
C. Spies, V. Haude, and R. Fitzner, et al., Serum cardiac troponin T as a prognostic marker in early sepsis, Chest 113, 1055–1063 (1998).
T. M. Guest, A. V. Ramanathan, and P. G. Tuteur, et al., Myocardial injury in critically ill patients: a frequently unrecognized complication, JAMA 273, 1945–1949 (1995).
S. P. Rao, S. Miller, and R. Rosenbaum, et al., Cardiac troponin I and cardiac enzymes after electrophysiologic studies, ablations, and defibrillator implantations, Am. J. Cardiol. 84(4), 470, A9 (1999).
J. J. Allan, R. D. Feld, and A. A. Russell, et al., Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion, J. Am. Coll. Cardiol. 30, 1052–1056 (1997).
J. Zimmerman, R. Fromm, and D. Meyer, et al., Diagnostic marker cooperative study for the diagnosis of myocardial infarction, Circulation 99, 1671–1677 (1999).
J. Kamblock, L. Payot, and B. Iung, et al., Does rheumatic myocarditis really exists? Systematic study with echocardiography and cardiac troponin I blood levels, Eur. Heart J. 24, 855–862 (2003).
B. Lauer, C. Niederau, and U. Kuhl, et al., Cardiac troponin T in the diagnosis and follow up of suspected myocarditis, Dtsch. Med. Wochenschr. 123, 409–417 (1998).
J. Soongswang, K. Durongpisitkul, and S. Ratanarapee, et al., Cardiac troponin T: its role in the diagnosis of clinically suspected acute myocarditis and chronic in children, Pediatr. Cardiol. 23, 531–535 (2002).
S. Abe, S. Arima, and T. Yamashita, et al., Early assessment of reperfusion therapy using cardiac troponin T, J. Am. Coll. Cardiol. 23, 1382–1389 (1994).
M. A. Karim, M. S. Shinn, and H. Oskarsson, et al., Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty, Am. J. Cardiol. 76, 521–523 (1995).
B. Riou, S. Dreux, and S. Roche, et al., Circulating cardiac troponin T in potential heart transplant donors, Circulation 92, 409–414 (1995).
R. J. Aviles, A. T. Askari, and B. Lindahl, et al., Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction, N. Engl. J. Med. 346, 2047–2052 (2002).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this paper
Cite this paper
Toyo-oka, T., Kumagai, H. (2007). Cardiac Troponin Levels as a Preferable Biomarker of Myocardial Cell Degradation. In: Ebashi, S., Ohtsuki, I. (eds) Regulatory Mechanisms of Striated Muscle Contraction. Advances in Experimental Medicine and Biology, vol 592. Springer, Tokyo. https://doi.org/10.1007/978-4-431-38453-3_20
Download citation
DOI: https://doi.org/10.1007/978-4-431-38453-3_20
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-38451-9
Online ISBN: 978-4-431-38453-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)